BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17084016)

  • 1. Dynamics of the nucleated polymerization model of prion replication.
    Rubenstein R; Gray PC; Cleland TJ; Piltch MS; Hlavacek WS; Roberts RM; Ambrosiano J; Kim JI
    Biophys Chem; 2007 Feb; 125(2-3):360-7. PubMed ID: 17084016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.
    Saborio GP; Permanne B; Soto C
    Nature; 2001 Jun; 411(6839):810-3. PubMed ID: 11459061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
    Piening N; Weber P; Giese A; Kretzschmar H
    Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mathematical analysis of the dynamics of prion proliferation.
    Greer ML; Pujo-Menjouet L; Webb GF
    J Theor Biol; 2006 Oct; 242(3):598-606. PubMed ID: 16753184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
    Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
    Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
    Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
    J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The highways and byways of prion protein trafficking.
    Campana V; Sarnataro D; Zurzolo C
    Trends Cell Biol; 2005 Feb; 15(2):102-11. PubMed ID: 15695097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups.
    Lucassen R; Nishina K; Supattapone S
    Biochemistry; 2003 Apr; 42(14):4127-35. PubMed ID: 12680767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
    Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
    Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperefficient PrP Sc amplification of mouse-adapted BSE and scrapie strain by protein misfolding cyclic amplification technique.
    Fujihara A; Atarashi R; Fuse T; Ubagai K; Nakagaki T; Yamaguchi N; Ishibashi D; Katamine S; Nishida N
    FEBS J; 2009 May; 276(10):2841-8. PubMed ID: 19459939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling and analysis of prion dynamics in the presence of a chaperone.
    Kumar R; Murali P
    Math Biosci; 2008 May; 213(1):50-5. PubMed ID: 18362035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form.
    Jansen K; Schäfer O; Birkmann E; Post K; Serban H; Prusiner SB; Riesner D
    Biol Chem; 2001 Apr; 382(4):683-91. PubMed ID: 11405232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of prions in blood.
    Castilla J; Saá P; Soto C
    Nat Med; 2005 Sep; 11(9):982-5. PubMed ID: 16127436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular dynamics studies on the NMR and X-ray structures of rabbit prion proteins.
    Zhang J; Zhang Y
    J Theor Biol; 2014 Feb; 342():70-82. PubMed ID: 24184221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
    Surewicz WK; Jones EM; Apetri AC
    Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chaperonin-mediated de novo generation of prion protein aggregates.
    Stöckel J; Hartl FU
    J Mol Biol; 2001 Nov; 313(4):861-72. PubMed ID: 11697909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.